About SM Companion

Just as many people with rare diseases and disorders such as systemic mastocytosis (SM) suffer from unmet medical needs, so too do they suffer from unmet informational needs on the web. People diagnosed with rare diseases and their families often search in vein for answers to their questions, or find news and perspectives that are written for doctors, researchers, and investors — but not for patients and caregivers.

SM Companion is part of Haymarket Media’s Rare Disease Companion network of websites, which fills the wide informational gaps that exist for rare disease patient communities on the web. SM Companion provides people who have the SM diagnosis and their families with news, educational materials, and trustworthy insights that give them the answers and support that they are looking for.

The editorial team at SM Companion:

  • Publishes news and educational articles about the science, research, and therapeutic advancements for treating SM in a style that patients and families can easily understand.
  • Works directly with people who have direct knowledge and expertise about SM, having experienced it firsthand, ensuring that our articles are accurate and appropriate for the SM community.
  • Tells powerful and exclusive stories about people and their families who have persevered through the challenges and difficulties of SM.
  • Offers insights into the SM patient journey and how others have navigated every facet of the SM diagnosis.

All Rare Disease Companion websites offer readers industry-leading accessibility features that make it easier for people with rare diseases and disabilities to read and navigate the website. Haymarket Media is committed to serving the needs of the rare disease community — please contact a member of our staff if you encounter any accessibility issues on the website.

Haymarket Media also supports healthcare providers and the care teams who treat people with SM at Rare Disease Advisor (RDA). Be sure to visit RDA’s SM Junction for exclusive news, resources, and perspectives geared toward the HCP community.